Overview

The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)

Status:
Completed

Trial end date:
2008-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate which combination therapy is more effective for improving the blood pressure (BP) and reducing target organ damage in Japanese hypertensive patients: Angiotensin II receptor blocker (ARB) plus calcium channel blocker (CCB) or ARB plus diuretics.

Phase:

Phase 4

Details

Lead Sponsor:

Jichi Medical University

Treatments:

Calcium Channel Blockers
Diuretics
Hydrochlorothiazide
Olmesartan
Olmesartan Medoxomil